TLPH Stock Price
Talphera, Inc.
TLPH stock price is $1.06 (-0.93% on the day), giving Talphera, Inc. a market cap of $55.02M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
TLPH Stock Overview
- Price
- $1.06
- Previous close
- $1.07
- Open
- $1.05
- Market cap
- $55.02M
- P/E ratio
- -3.9
- 52-week range
- $0.69 - $1.57
- 1-year price target
- $3.17
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Exchange
- NSC
- MarketXLS Rank
- 39
About Talphera, Inc.
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TLPH | $1.06 | -0.9% | 48.55K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |